Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ISONIAZID; PYRAZINAMIDE; RIFAMPIN
- Short-course Regimens for the Treatment of Pulmonary Tuberculosis
- Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment
- Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
- Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
- A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2
- Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
- Azacytidine During Anti-tuberculosis Therapy
- Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis
- Pilot Clinical Trial of PRS TB Regimen I - Phase II
- Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin
- Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
- A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis
- Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis
- TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
- NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
- Assessing PA-824 for Tuberculosis (the APT Trial)
- Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)
- Trial of High-Dose Rifampin in Patients With TB
- Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
- Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment
- Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness
- Study of Daily Rifapentine for Pulmonary Tuberculosis
- Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis
- Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis
- TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
- Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity
- A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy
- Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis
- A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis
- TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment
- TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment
- TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment
- Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis
- TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance
- The Treatment of Tuberculosis in HIV-Infected Patients
- Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
- Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
- Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
Clinical trials list
click for details